Tag
Bombay Stock Exchange
5 articles
Corporate activity on the Bombay Stock Exchange is currently characterized by a mix of strategic shifts and procedural adjustments. Rajputana Investment reported a significant 89% drop in net profit for fiscal year 2026, alongside a notice for its upcoming AGM and a resolution to renew a related-party lease, while Arvaya Healthcare is set to consider an acquisition of Sushodha Institute of Gastroenterology alongside a potential share swap and rights issue. Elsewhere, Pratik Panels has postponed its rights issue committee meeting, and Sonal Adhesives has denied any pending price-sensitive information, highlighting a period of operational and financial reassessment for listed companies. These developments suggest increased scrutiny and strategic maneuvering within the Indian equity market, potentially impacting investor sentiment and requiring careful evaluation of underlying fundamentals.
Pearl Green Promoter Group Sells 29,400 Shares
Promoter group member Jhala Rekhadevi Vijaysingh sold 29,400 equity shares in Pearl Green Clubs and Resorts via open market transactions.
The sale reduced her holding from 3.99% to 2.89% of the compan
Pratik Panels Rights Issue Meeting Postponed to July 15
Pratik Panels postpones Rights Issue Committee meeting to July 15, 2026 due to pending stock exchange approvals.
The meeting will fix record date, issue price, and entitlement ratio for the proposed r
Arvaya Healthcare Board Meeting on Acquisition, Preferential Issue
• Arvaya Healthcare board meeting scheduled July 11, 2026 to consider acquisition of Sushodha Institute of Gastroenterology.
• Agenda includes preferential equity issuance via share swap and potential
Sonal Adhesives Denies Pending Price Sensitive Information
• Sonal Adhesives responded to a BSE clarification request dated 01/07/2026 regarding significant share price movement.
• The company stated no pending price-sensitive information or announcements con
Rajputana Investment FY26 Net Profit Plunges 89%
Submitted 84th Annual Report for FY 2025-26 to BSE under SEBI Regulation 34(1), detailing a sharp 89% decline in net profit to ₹4.08 lakh.
Notice for 84th AGM on July 15, 2026, includes a special reso